Announcements Trials
Browse Landscape

Status

No longer available 1Available 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 41Observational 5Expanded_access 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Lymphangioma 1

Interventions

abemaciclib 2Alpelisib 2zenocutuzumab 1tucatinib 1selpercatinib 1ribociclib 1pegilodecakin 1iniparib 1eribulin 1Proton Pump Inhibitors 1Lapatinib 1Hydrocortisone 1Everolimus 1Capecitabine 1Ado-Trastuzumab Emtansine 1AM0010 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Expanded_access × Breast Neoplasms × Alpelisib × Clear all
NCT04085653 2026-04-14

Managed Access Programs for BYL719, Alpelisib

Novartis

Available
Breast

Breast Neoplasms

NCT03706573 2021-07-19

Managed Access Program to Provide Alpelisib for Patients With HR+ Advanced or Metastatic Breast Cancer

Novartis

No longer available
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡